Form 4: Elanco EVP Acquires Deferred Stock Units

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 56.6301 deferred stock units.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc. (ELAN), acquired additional deferred stock units.
• The transaction involved the acquisition of 56.6301 deferred stock units on February 20, 2026.
• Each deferred stock unit represents the right to receive one share of Elanco common stock or its cash equivalent.
• These units settle in cash or shares upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
• Following this transaction, Modi beneficially owns a total of 7,651.0914 deferred stock units.
• The implied value per unit for the derivative security was $24.98.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as an executive's acquisition of additional company stock equivalents, even through a deferred compensation plan, typically indicates confidence in the company's long-term prospects and aligns management interests with shareholders.

Positives

• An executive acquiring additional company stock equivalents can signal confidence in the company's future performance and aligns management interests with shareholder value.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it is a report of a past insider transaction.

Management Comments

• Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
• Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

StockSavvy.ai notes that insider acquisitions, even of deferred units, are often viewed positively by the market as they align executive interests with shareholder value, particularly in the animal health sector where long-term growth prospects are often tied to innovation and market penetration.

Comparison to Industry Standards

• Insider transactions like this are standard practice for executive compensation and long-term incentive plans across various industries, including pharmaceuticals and animal health.
• Companies such as Zoetis Inc. (ZTS) and IDEXX Laboratories, Inc. (IDXX) also utilize similar deferred compensation structures for their executives to encourage retention and performance alignment.

Corporate Governance

Related Party Transactions

• The acquisition of deferred stock units by an executive is a related-party transaction, which is a standard component of executive compensation plans.

Stakeholder Impact

• Shareholders: The acquisition by an executive may be seen as a positive signal of management confidence, potentially influencing investor sentiment.
• Employees: No direct impact on general employees is indicated by this filing.

Key Dates

Recommendation

While an executive acquiring additional deferred stock units is generally a positive indicator of confidence, this single transaction, which appears to be part of a routine compensation plan, does not provide sufficient new information to alter a broader investment thesis. It primarily reinforces alignment between management and shareholder interests, suggesting a 'hold' position for existing investors or a neutral stance for potential new investors, pending more comprehensive financial updates.

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Transaction, Deferred Stock Units, Rajeev A. Modi, Executive Compensation, Stock Acquisition